Back to Journals

Open Access Journal of Clinical Trials

Professor Frankel

Chief of medical oncology, USA Mitchell Cancer Institute, Alabama, USA, United States

Professor Frankel

Editor-in-Chief:  Professor Arthur E. Frankel

Dr. Arthur Frankel is the chief of medical oncology at USA Mitchell Cancer Institute, Alabama, USA.

Dr. Frankel earned his MD from Harvard Medical School and conducted his medicine internship at Yale University. Soon after completing his degree, Dr. Frankel began as a research scientist with the National Institute of Health and later completed his medicine residency and oncology fellowship at Stanford University. He is board certified in internal medicine, medical oncology and hematology. Dr. Frankel is a member of the American Society of Clinical Oncology, American Society of Hematology and American Association of Cancer Research.

Dr. Frankel's main focus is combining the clinical practice of hematology/oncology with an investigative cancer drug development program to better move targeted cancer therapeutics into the clinical setting. He has participated in the development of targeted peptide toxins also called immunotoxins for melanoma, breast cancer, ovarian cancer, leukemia, lymphoma, chronic pain, prostate cancer, and thyroid cancer. He has performed phase I clinical trials for many of these agents. He has over 190 peer-reviewed articles, has edited three books, organized for international symposia and received grants from the American Cancer Society, the Leukemia and Lymphoma Society, NIH and the Van Andel Foundation.

Editorial Board

Abdelhamid Attia, Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Cairo, Cairo, Egypt

Fiona Bath-Hextall, Faculty of Medicine and Health Sciences, Queen's Medical Center, The University of Nottingham, Nottingham, UK

Denise Bonds, Departments of Public Health Sciences and Medicine, University of Virginia, Charlottesville, VA, USA

Adam M. Brufsky, Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, USA

Rudolph J. Castellani, Professor of Pathology, Director, Center for Neuropathology, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA

Mario Cazzola, Professor of Respiratory Medicine, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy

William Checkley, Assistant Professor, Medical Director, Johns Hopkins Medicine International, Baltimore, Maryland, USA

E. David Crawford, Professor, University of Colorado Cancer Center, University of Colorado Health Sciences Center, Denver, CO, USA

Tarek El-Bialy, Department of Dentistry and Biomedical Engineering, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada

Cristiano Ferlini, Professor, Department of Obstetrics and Gynaecology, Catholic University of the Sacred Heart, Rome, Italy

Stephen Gitelman, Professor, Department of Clinical Pediatrics, University of California, San Francisco, CA, USA

Robert Hauser, Professor, Department of Neurology, University of South Florida College of Medicine, FL, USA

Mallory O. Johnson, Department of Medicine, University of California, San Francisco, CA, USA

Roger S. McIntyre, M.D., FRCPC, Professor of Psychiatry and Pharmacology, University of Toronto; Head, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada

Yuko Y. Palesch, Professor, Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, Charleston, SC, USA

Ian S. Zagon, Professor, Department of Neural and Behavioural Sciences, Pennsylvania State University Milton S. Hershey Medical Center, Hershey, PA, USA